Takeda

Seattle Genetics `Guided Missile' Drug Blasts Rare Lymphoma in New Study
Bloomberg
Tue, 12/7/10 - 12:07 pm
Seattle Genetics
lymphoma
Takeda
Seattle Genetics and Millennium Report Positive Data from Pivotal Trial of Brentuximab Vedotin (SGN-35) in Relapsed or Refractory Hodgkin Lymphoma at ASH Annual Meeting
Yahoo/BusinessWire
Sun, 12/5/10 - 11:47 am
Seattle Genetics
Millennium
brentuximab vedotin
SGN-35
Hodgkin's lymphoma
Takeda
FDA: Proposed Weight Loss Drug Contrave Raises Blood Pressure
WSJ
Sat, 12/4/10 - 12:33 pm
Takeda
Contrave
weight loss
obesity. Orexigen Therapeutics
Johnson & Johnson, Takeda Units Recall Velcade Drug After Particle Reports
Bloomberg
Fri, 11/19/10 - 11:17 am
JNJ
Takeda
Velcade
Top 15 Pharma R&D Budgets
Fierce Pharma
Thu, 11/18/10 - 08:47 am
R&D
Roche
Pfizer
Novartis
JNJ
Sanofi
GSK
Merck
Takeda
AstraZeneca
Eli Lilly
Boehringer Ingelheim
Bristol-Myers Squibb
Abbott Laboratories
Daiichi Sankyo
Astellas
No White Knight for Genzyme
Minyanville
Mon, 11/15/10 - 06:25 pm
Sanofi
Takeda
Genzyme
M&A
Report: Termeer's value hunt yields buyout interest
Fierce Pharma
Mon, 11/15/10 - 12:02 pm
Henri Termeer
Genzyme
Takeda
Sanofi
Genzyme in Talks to Sell Itself to Japan’s Takeda, Mail Says
Bloomberg
Mon, 11/15/10 - 10:39 am
Takeda
Genzyme
M&A
Takeda and Sage Bionetworks Form CNS disease Research Alliance
PipeLine Review
Sun, 11/14/10 - 01:05 pm
Takeda
Sage Bionetworks
CNS
China Biotech Week in Review: Big Week for IPOs
Seeking Alpha
Sun, 10/24/10 - 12:46 pm
China
Sihuan
Shanghai Pharmaceutical
ShangPharma
Pfizer
Takeda
Livzon Pharmaceutical
ProMetic Life Sciences
With Meridia Gone, Can’t We Just Admit There’s No Money in Diet Drugs?
BNET Pharma
Mon, 10/11/10 - 05:55 pm
Meridia
diet drugs
Abbott Laboratories
GSK
Roche
Allergan
Novo Nordisk
Sanofi
Merck
Eli Lilly
Amylin
Takeda
Orexigen
Seattle Genetics, Takeda Drug Shrinks Lymphoma Patients' Tumors in Study
Bloomberg
Mon, 09/27/10 - 10:47 am
Seattle Genetics
Takeda
lymphoma
Hodgkin's lymphoma
Takeda Seeks 10-Fold Jump in China Sales by 2015, Hasegawa Says
Bloomberg
Wed, 09/22/10 - 09:58 am
Takeda
China
FDA reviewing safety of Actos diabetes drug
MSNBC
Sat, 09/18/10 - 11:28 am
Actos
diabetes
Takeda
Speculative Bubble Growing Around Diet Drugs
BNET Pharma
Tue, 09/14/10 - 05:42 pm
Arena Pharmaceuticals
obesity
Takeda
Orexigen
Contrave
Abbott Laboratories
Meridia
Qnexa
Vivus
Alnylam Evenly Poised
Yahoo/Zacks.com
Fri, 09/10/10 - 08:15 am
Alnylam
Novartis
Biogen Idec
Roche
Isis Pharmaceuticals
Cubist Pharmaceuticals
Takeda
earnings
Volume Hunter: Diet Stocks Lift Biotech
Yahoo/IndieResearch
Thu, 09/2/10 - 04:01 pm
diet drugs
biotech
Arena Pharmaceuticals
Dendreon
Provenge
Exelixis
Vivus
Orexigen
Takeda
Contrave
Martek
Orexigen, Takeda Tie Knot on Obesity Drug
TheStreet.com
Thu, 09/2/10 - 08:18 am
Orexigen
Takeda
obesity
Contrave
partnerships
Takeda's Actos Has Same Heart Risks as Glaxo's Avandia, Researchers Find
Bloomberg
Wed, 08/25/10 - 07:53 am
diabetes
Takeda
Actos
GSK
Avandia
Takeda Says Lifestyle-Disease Drugs Will Drive Growth
Bloomberg
Thu, 08/19/10 - 10:33 am
Takeda
diabetes
Actos
generics

Pages